FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2344778889> ?p ?o ?g. }

• W2344778889 endingPage "32865" @default.
• W2344778889 startingPage "32854" @default.
• W2344778889 abstract "// Ying Wang 1, * , Xue-Song Wu 2, * , Jing He 3, 4, * , Tianjiao Ma 5 , Wei Lei 1 , Zhen-Ya Shen 1 1 Department of Cardiovascular Surgery, The First Affiliated Hospital and Institute for Cardiovascular Science, Soochow University, Suzhou, Jiangsu, China 2 School of Humanities and Social Science, Harbin Medical University, Harbin, Heilongjiang, China 3 Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China 4 Department of Experimental Research, Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China 5 Department of Internal Medicine, Harbin Medical University, Harbin, Heilongjiang, China * These authors contributed equally to this work Correspondence to: Zhen-Ya Shen, email: uuzyshen@aliyun.com Keywords: TP53, rare variant, GWAS, apoptosis, polymorphism Received: March 01, 2016      Accepted: April 02, 2016      Published: April 27, 2016 ABSTRACT Polymorphisms in TP53 are involved in the progression of different types of cancer. A rare novel TP53 variant (rs78378222 A > C allele) was found via whole-genome sequencing in 2011. This variant was shown to significantly increase the risk of glioma, colorectal adenoma and prostate cancer. Functional analysis further revealed that this variant hindered TP53 expression and its downstream effect on apoptosis. Several studies have investigated the relationship between rs78378222 and cancer susceptibility. However, the results were not consistent. We conducted the first meta-analysis to give a more credible assessment on the association about this variant and cancer risk. Our meta-analysis included 34 studies consisting of 36599 cases and 91272 controls. These studies were mostly on the basis of high-grade data from Genome-wide association studies (GWASs). The results indicated that TP53 rs78378222 was significantly associated with an increased risk of overall cancer (AC vs. AA: OR = 1.511, 95% CI = 1.285–1.777). Furthermore, stratified analyses indicated that rs78378222 increased the risk of nervous system cancer, skin cancer and other cancer. To summarize, this meta-analysis suggested that rs78378222 C allele is a potent risk factor for overall cancer." @default.
• W2344778889 created "2016-06-24" @default.
• W2344778889 creator A5031091922 @default.
• W2344778889 creator A5042995444 @default.
• W2344778889 creator A5054398168 @default.
• W2344778889 creator A5058837931 @default.
• W2344778889 creator A5078170323 @default.
• W2344778889 creator A5084144373 @default.
• W2344778889 date "2016-04-27" @default.
• W2344778889 modified "2023-10-17" @default.
• W2344778889 title "A novel TP53 variant (rs78378222 A > C) in the polyadenylation signal is associated with increased cancer susceptibility: evidence from a meta-analysis" @default.
• W2344778889 cites W1964319241 @default.
• W2344778889 cites W1972933475 @default.
• W2344778889 cites W1976969965 @default.
• W2344778889 cites W1990991800 @default.
• W2344778889 cites W2004273407 @default.
• W2344778889 cites W2007010240 @default.
• W2344778889 cites W2034882416 @default.
• W2344778889 cites W2044433401 @default.
• W2344778889 cites W2049137769 @default.
• W2344778889 cites W2070116573 @default.
• W2344778889 cites W2073074039 @default.
• W2344778889 cites W2079809846 @default.
• W2344778889 cites W2079852484 @default.
• W2344778889 cites W2091808830 @default.
• W2344778889 cites W2092794481 @default.
• W2344778889 cites W2112396116 @default.
• W2344778889 cites W2118071133 @default.
• W2344778889 cites W2124935187 @default.
• W2344778889 cites W2132546867 @default.
• W2344778889 cites W2134833483 @default.
• W2344778889 cites W2138418922 @default.
• W2344778889 cites W2143992683 @default.
• W2344778889 cites W2149278033 @default.
• W2344778889 cites W2152733195 @default.
• W2344778889 cites W2154799239 @default.
• W2344778889 cites W2156098321 @default.
• W2344778889 cites W2164349814 @default.
• W2344778889 cites W2272616382 @default.
• W2344778889 cites W2917837889 @default.
• W2344778889 cites W2991792334 @default.
• W2344778889 cites W56033953 @default.
• W2344778889 doi "https://doi.org/10.18632/oncotarget.9056" @default.
• W2344778889 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5078057" @default.
• W2344778889 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27147571" @default.
• W2344778889 hasPublicationYear "2016" @default.
• W2344778889 type Work @default.
• W2344778889 sameAs 2344778889 @default.
• W2344778889 citedByCount "22" @default.
• W2344778889 countsByYear W23447788892016 @default.
• W2344778889 countsByYear W23447788892017 @default.
• W2344778889 countsByYear W23447788892018 @default.
• W2344778889 countsByYear W23447788892019 @default.
• W2344778889 countsByYear W23447788892020 @default.
• W2344778889 countsByYear W23447788892021 @default.
• W2344778889 countsByYear W23447788892022 @default.
• W2344778889 countsByYear W23447788892023 @default.
• W2344778889 crossrefType "journal-article" @default.
• W2344778889 hasAuthorship W2344778889A5031091922 @default.
• W2344778889 hasAuthorship W2344778889A5042995444 @default.
• W2344778889 hasAuthorship W2344778889A5054398168 @default.
• W2344778889 hasAuthorship W2344778889A5058837931 @default.
• W2344778889 hasAuthorship W2344778889A5078170323 @default.
• W2344778889 hasAuthorship W2344778889A5084144373 @default.
• W2344778889 hasBestOaLocation W23447788891 @default.
• W2344778889 hasConcept C121608353 @default.
• W2344778889 hasConcept C126322002 @default.
• W2344778889 hasConcept C143998085 @default.
• W2344778889 hasConcept C17744445 @default.
• W2344778889 hasConcept C191935318 @default.
• W2344778889 hasConcept C199539241 @default.
• W2344778889 hasConcept C512399662 @default.
• W2344778889 hasConcept C556039675 @default.
• W2344778889 hasConcept C71924100 @default.
• W2344778889 hasConcept C95190672 @default.
• W2344778889 hasConceptScore W2344778889C121608353 @default.
• W2344778889 hasConceptScore W2344778889C126322002 @default.
• W2344778889 hasConceptScore W2344778889C143998085 @default.
• W2344778889 hasConceptScore W2344778889C17744445 @default.
• W2344778889 hasConceptScore W2344778889C191935318 @default.
• W2344778889 hasConceptScore W2344778889C199539241 @default.
• W2344778889 hasConceptScore W2344778889C512399662 @default.
• W2344778889 hasConceptScore W2344778889C556039675 @default.
• W2344778889 hasConceptScore W2344778889C71924100 @default.
• W2344778889 hasConceptScore W2344778889C95190672 @default.
• W2344778889 hasIssue "22" @default.
• W2344778889 hasLocation W23447788891 @default.
• W2344778889 hasLocation W23447788892 @default.
• W2344778889 hasLocation W23447788893 @default.
• W2344778889 hasLocation W23447788894 @default.
• W2344778889 hasOpenAccess W2344778889 @default.
• W2344778889 hasPrimaryLocation W23447788891 @default.
• W2344778889 hasRelatedWork W1984536088 @default.
• W2344778889 hasRelatedWork W2350270224 @default.
• W2344778889 hasRelatedWork W2351486628 @default.
• W2344778889 hasRelatedWork W2354620178 @default.
• W2344778889 hasRelatedWork W2383989146 @default.
• W2344778889 hasRelatedWork W2390481881 @default.

• next